About Azipro
Azipro 250 mg Cipla is a macrolide antibiotic formulation containing azithromycin as the active pharmaceutical ingredient. This research compound belongs to the azalide subclass of macrolide antibiotics and serves as a valuable tool for investigating antimicrobial mechanisms, bacterial resistance patterns, and pharmacokinetic properties in laboratory environments. Researchers studying antibiotic efficacy and resistance mechanisms will find this formulation particularly useful for Stroid UK Shop applications.
Laboratory Applications
Research scientists examine Azipro 250 mg for its antimicrobial spectrum against gram-positive and gram-negative bacteria in controlled laboratory settings. Studies focus on investigating the compound’s mechanism of action through protein synthesis inhibition at the 50S ribosomal subunit. Researchers analyse tissue penetration properties, intracellular accumulation patterns, and extended half-life characteristics that distinguish this macrolide from other antibiotic classes. The formulation enables investigation of post-antibiotic effects and immunomodulatory properties observed in various research models. Scientists studying azithromycin research applications utilise this compound for comparative efficacy studies.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Azithromycin |
| Strength | 250 mg per unit |
| Manufacturer | Cipla |
| CAS Number | 83905-01-5 |
| Molecular Formula | C₃₈H₇₂N₂O₁₂ |
| Molecular Weight | 748.98 g/mol |
| Storage Temperature | Room temperature, dry conditions |
Researchers investigating antibiotic mechanisms often compare results with selective androgen receptor modulators and peptide research compounds for comprehensive pharmaceutical studies.
Research Compliance
Azipro 250 mg Cipla is supplied exclusively for in-vitro laboratory research purposes. This compound is not intended for human consumption, veterinary applications, or therapeutic use. Researchers must handle this material according to appropriate laboratory safety protocols and institutional guidelines. All investigations should comply with relevant research ethics frameworks and regulatory requirements governing antimicrobial research compounds in laboratory environments.
